Naidech AM - Search Results

1

Agitation, Delirium, and Cognitive Outcomes in Intracerebral Hemorrhage.

Rosenthal LJ, Francis BA, Beaumont JL, Cella D, Berman MD, Maas MB, Liotta EM, Askew R, Naidech AM. Rosenthal LJ, et al. Among authors: naidech am. Psychosomatics. 2017 Jan-Feb;58(1):19-27. doi: 10.1016/j.psym.2016.07.004. Epub 2016 Aug 5. Psychosomatics. 2017. PMID: 27665997 Free PMC article.

2

Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage.

Naidech AM, Kreiter KT, Janjua N, Ostapkovich N, Parra A, Commichau C, Connolly ES, Mayer SA, Fitzsimmons BF. Naidech AM, et al. Stroke. 2005 Mar;36(3):583-7. doi: 10.1161/01.STR.0000141936.36596.1e. Epub 2005 Jan 20. Stroke. 2005. PMID: 15662039

3

Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage.

Naidech AM, Jovanovic B, Wartenberg KE, Parra A, Ostapkovich N, Connolly ES, Mayer SA, Commichau C. Naidech AM, et al. Crit Care Med. 2007 Oct;35(10):2383-9. doi: 10.1097/01.CCM.0000284516.17580.2C. Crit Care Med. 2007. PMID: 17717494

4

Packed red blood cell transfusion causes greater hemoglobin rise at a lower starting hemoglobin in patients with subarachnoid hemorrhage.

Naidech AM, Kahn MJ, Soong W, Green D, Batjer HH, Bleck TP. Naidech AM, et al. Neurocrit Care. 2008;9(2):198-203. doi: 10.1007/s12028-008-9113-8. Neurocrit Care. 2008. PMID: 18542851 Clinical Trial.

5

Fever burden and functional recovery after subarachnoid hemorrhage.

Naidech AM, Bendok BR, Bernstein RA, Alberts MJ, Batjer HH, Watts CM, Bleck TP. Naidech AM, et al. Neurosurgery. 2008 Aug;63(2):212-7; discussion 217-8. doi: 10.1227/01.NEU.0000320453.61270.0F. Neurosurgery. 2008. PMID: 18797350

6

Medical complications drive length of stay after brain hemorrhage: a cohort study.

Naidech AM, Bendok BR, Tamul P, Bassin SL, Watts CM, Batjer HH, Bleck TP. Naidech AM, et al. Neurocrit Care. 2009;10(1):11-9. doi: 10.1007/s12028-008-9148-x. Epub 2008 Sep 27. Neurocrit Care. 2009. PMID: 18821035

7

How patients die after intracerebral hemorrhage.

Naidech AM, Bernstein RA, Bassin SL, Garg RK, Liebling S, Bendok BR, Batjer HH, Bleck TP. Naidech AM, et al. Neurocrit Care. 2009;11(1):45-9. doi: 10.1007/s12028-009-9186-z. Epub 2009 Feb 6. Neurocrit Care. 2009. PMID: 19199079

8

Platelet activity and outcome after intracerebral hemorrhage.

Naidech AM, Bernstein RA, Levasseur K, Bassin SL, Bendok BR, Batjer HH, Bleck TP, Alberts MJ. Naidech AM, et al. Ann Neurol. 2009 Mar;65(3):352-6. doi: 10.1002/ana.21618. Ann Neurol. 2009. PMID: 19334079

9

Reduced platelet activity is more common than reported anti-platelet medication use in patients with intracerebral hemorrhage.

Naidech AM, Bassin SL, Bernstein RA, Batjer HH, Alberts MJ, Lindholm PF, Bleck TP. Naidech AM, et al. Neurocrit Care. 2009 Dec;11(3):307-10. doi: 10.1007/s12028-009-9219-7. Neurocrit Care. 2009. PMID: 19381881

10

Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage.

Naidech AM, Jovanovic B, Liebling S, Garg RK, Bassin SL, Bendok BR, Bernstein RA, Alberts MJ, Batjer HH. Naidech AM, et al. Stroke. 2009 Jul;40(7):2398-401. doi: 10.1161/STROKEAHA.109.550939. Epub 2009 May 14. Stroke. 2009. PMID: 19443791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

162 results

Search Page